BDBM50162830 1-(1-{(R)-3-[5-Acetyl-3-(4-chloro-3-methyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxy-propyl}-piperidin-4-yl)-6-chloro-1,3-dihydro-benzoimidazol-2-one::CHEMBL181413
SMILES CC(=O)N1CCc2c(C1)c(nn2C[C@H](O)CN1CCC(CC1)n1c2cc(Cl)ccc2[nH]c1=O)-c1ccc(Cl)c(C)c1
InChI Key InChIKey=SVNPCROCRJHPKS-HSZRJFAPSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 50162830
TargetCathepsin S(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 350nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair